triazolam has been researched along with Narcolepsy in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Studies of long-term administration of triazolam are required to determine if the improvement of nocturnal sleep is maintained." | 2.67 | Short-term triazolam use improves nocturnal sleep of narcoleptics. ( Aloe, FS; Ledereich, PS; Snyder, M; Starz, KE; Thorpy, MJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thorpy, MJ | 1 |
| Snyder, M | 1 |
| Aloe, FS | 1 |
| Ledereich, PS | 1 |
| Starz, KE | 1 |
1 trial available for triazolam and Narcolepsy
| Article | Year |
|---|---|
Short-term triazolam use improves nocturnal sleep of narcoleptics.
Topics: Adult; Arousal; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Male; Middle Aged; N | 1992 |